AAAAAA

   
Results: 1-25 | 26-37
Results: 1-25/37
TH1 AND TH2 ACTIVITY RAPIDLY DEVELOPING IN A SINGLE NODE
Authors: MACLENNAN ICM GULBRANSONJUDGE A TOELLNER KM
Citation: Icm. Maclennan et al., TH1 AND TH2 ACTIVITY RAPIDLY DEVELOPING IN A SINGLE NODE, Immunologist, 6(5), 1998, pp. 178-181
B-CELL RECEPTOR REGULATION OF PERIPHERAL B-CELLS
Authors: MACLENNAN ICM
Citation: Icm. Maclennan, B-CELL RECEPTOR REGULATION OF PERIPHERAL B-CELLS, Current opinion in immunology, 10(2), 1998, pp. 220-225
T-HELPER-1 (TH1) AND TH2 CHARACTERISTICS START TO DEVELOP DURING T-CELL PRIMING AND ARE ASSOCIATED WITH AN IMMEDIATE ABILITY TO INDUCE IMMUNOGLOBULIN CLASS SWITCHING
Authors: TOELLNER KM LUTHER SA SZE DMY CHOY RKW TAYLOR DR MACLENNAN ICM ACHAORBEA H
Citation: Km. Toellner et al., T-HELPER-1 (TH1) AND TH2 CHARACTERISTICS START TO DEVELOP DURING T-CELL PRIMING AND ARE ASSOCIATED WITH AN IMMEDIATE ABILITY TO INDUCE IMMUNOGLOBULIN CLASS SWITCHING, The Journal of experimental medicine, 187(8), 1998, pp. 1193-1204
ORIGIN AND PROPERTIES OF SOLUBLE CD21 (CR-2) IN HUMAN BLOOD
Authors: LING NR HARDIE DL JOHNSON GD MACLENNAN ICM
Citation: Nr. Ling et al., ORIGIN AND PROPERTIES OF SOLUBLE CD21 (CR-2) IN HUMAN BLOOD, Clinical and experimental immunology, 113(3), 1998, pp. 360-366
ORAL CLODRONATE REDUCES SKELETAL MORBIDITY IN MULTIPLE-MYELOMA
Authors: MCCLOSKEY EV MACLENNAN ICM DRAYSON MT CHAPMAN C DUNN J KANIS JR
Citation: Ev. Mccloskey et al., ORAL CLODRONATE REDUCES SKELETAL MORBIDITY IN MULTIPLE-MYELOMA, British Journal of Haematology, 102(1), 1998, pp. 6-6
MRC TRIAL OF INTERFERON-ALPHA-2B MAINTENANCE THERAPY IN FIRST PLATEAU-PHASE OF MULTIPLE-MYELOMA
Authors: DRAYSON MT CHAPMAN CE DUNN JA OLUJOHUNGBE AB MACLENNAN ICM
Citation: Mt. Drayson et al., MRC TRIAL OF INTERFERON-ALPHA-2B MAINTENANCE THERAPY IN FIRST PLATEAU-PHASE OF MULTIPLE-MYELOMA, British Journal of Haematology, 101(1), 1998, pp. 195-202
A RANDOMIZED TRIAL OF THE EFFECT OF CLODRONATE ON SKELETAL MORBIDITY IN MULTIPLE-MYELOMA
Authors: MCCLOSKEY EV MACLENNAN ICM DRAYSON MT CHAPMAN C DUNN J KANIS JA
Citation: Ev. Mccloskey et al., A RANDOMIZED TRIAL OF THE EFFECT OF CLODRONATE ON SKELETAL MORBIDITY IN MULTIPLE-MYELOMA, British Journal of Haematology, 100(2), 1998, pp. 317-325
THE CHANGING PREFERENCE OF T-CELL AND B-CELL FOR PARTNERS AS T-DEPENDENT ANTIBODY-RESPONSES DEVELOP
Authors: MACLENNAN ICM GULBRANSONJUDGE A TOELLNER KM CASAMAYORPALLEJA M CHAN E SZE DMY LUTHER SA ORBEA HA
Citation: Icm. Maclennan et al., THE CHANGING PREFERENCE OF T-CELL AND B-CELL FOR PARTNERS AS T-DEPENDENT ANTIBODY-RESPONSES DEVELOP, Immunological reviews, 156, 1997, pp. 53-66
SYK TYROSINE KINASE IS REQUIRED FOR THE POSITIVE SELECTION OF IMMATURE B-CELLS INTO THE RECIRCULATING B-CELL POOL
Authors: TURNER M GULBRANSONJUDGE A QUINN ME WALTERS AE MACLENNAN ICM TYBULEWICZ VLJ
Citation: M. Turner et al., SYK TYROSINE KINASE IS REQUIRED FOR THE POSITIVE SELECTION OF IMMATURE B-CELLS INTO THE RECIRCULATING B-CELL POOL, The Journal of experimental medicine, 186(12), 1997, pp. 2013-2021
VIRAL SUPERANTIGEN DRIVES EXTRAFOLLICULAR AND FOLLICULAR B-CELL DIFFERENTIATION LEADING TO VIRUS-SPECIFIC ANTIBODY-PRODUCTION
Authors: LUTHER SA GULBRANSONJUDGE A ACHAORBEA H MACLENNAN ICM
Citation: Sa. Luther et al., VIRAL SUPERANTIGEN DRIVES EXTRAFOLLICULAR AND FOLLICULAR B-CELL DIFFERENTIATION LEADING TO VIRUS-SPECIFIC ANTIBODY-PRODUCTION, The Journal of experimental medicine, 185(3), 1997, pp. 551-562
GAMMA-DELTA T-CELL HELP OF B-CELLS IS INDUCED BY REPEATED PARASITIC INFECTION, IN THE ABSENCE OF OTHER T-CELLS
Authors: PAO W WEN L SMITH AL GULBRANSONJUDGE A ZHENG B KELSOE G MACLENNAN ICM OWEN MJ HAYDAY AC
Citation: W. Pao et al., GAMMA-DELTA T-CELL HELP OF B-CELLS IS INDUCED BY REPEATED PARASITIC INFECTION, IN THE ABSENCE OF OTHER T-CELLS, Current biology, 6(10), 1996, pp. 1317-1325
CENTROCYTES RAPIDLY ADOPT A MEMORY B-CELL PHENOTYPE ON COCULTURE WITHAUTOLOGOUS GERMINAL CENTER T-CELL-ENRICHED PREPARATIONS
Authors: CASAMAYORPALLEJA M FEUILLARD J BALL J DREW M MACLENNAN ICM
Citation: M. Casamayorpalleja et al., CENTROCYTES RAPIDLY ADOPT A MEMORY B-CELL PHENOTYPE ON COCULTURE WITHAUTOLOGOUS GERMINAL CENTER T-CELL-ENRICHED PREPARATIONS, International immunology, 8(5), 1996, pp. 737-744
DIFFERENCES IN THE GERMINAL-CENTERS OF PALATINE TONSILS AND LYMPH-NODES
Authors: BRACHTEL EF WASHIYAMA M JOHNSON GD TENNERRACZ K RACZ P MACLENNAN ICM
Citation: Ef. Brachtel et al., DIFFERENCES IN THE GERMINAL-CENTERS OF PALATINE TONSILS AND LYMPH-NODES, Scandinavian journal of immunology, 43(3), 1996, pp. 239-247
IMMUNOGLOBULIN SWITCH TRANSCRIPT PRODUCTION IN-VIVO RELATED TO THE SITE AND TIME OF ANTIGEN-SPECIFIC B-CELL ACTIVATION
Authors: TOELLNER KM GULBRANSONJUDGE A TAYLOR DR SZE DMY MACLENNAN ICM
Citation: Km. Toellner et al., IMMUNOGLOBULIN SWITCH TRANSCRIPT PRODUCTION IN-VIVO RELATED TO THE SITE AND TIME OF ANTIGEN-SPECIFIC B-CELL ACTIVATION, The Journal of experimental medicine, 183(5), 1996, pp. 2303-2312
GERMINAL CENTER FORMATION IN MICE LACKING ALPHA-BETA T-CELLS
Authors: DIANDA L GULBRANSONJUDGE A PAO W HAYDAY AC MACLENNAN ICM OWEN MJ
Citation: L. Dianda et al., GERMINAL CENTER FORMATION IN MICE LACKING ALPHA-BETA T-CELLS, European Journal of Immunology, 26(7), 1996, pp. 1603-1607
INTERFERON-ALPHA-2B TREATMENT USED IN PLATEAU-PHASE OF MULTIPLE-MYELOMA INCREASES RELAPSE-FREE INTERVAL BUT NOT OVERALL SURVIVAL
Authors: DRAYSON MT DUNN JA OLUJOHUNGBE AB MACLENNAN ICM
Citation: Mt. Drayson et al., INTERFERON-ALPHA-2B TREATMENT USED IN PLATEAU-PHASE OF MULTIPLE-MYELOMA INCREASES RELAPSE-FREE INTERVAL BUT NOT OVERALL SURVIVAL, British Journal of Haematology, 93, 1996, pp. 208-208
PREDNISOLONE ADDED TO THE ABCM AS TREATMENT FOR MULTIPLE-MYELOMA INCREASES SEROLOGICAL RESPONSES BUT NOT OVERALL SURVIVAL OR THE NUMBER OF STABLE CLINICAL-RESPONSES
Authors: OLUJOHUNGBE AB DUNN JA DRAYSON MT MACLENNAN ICM
Citation: Ab. Olujohungbe et al., PREDNISOLONE ADDED TO THE ABCM AS TREATMENT FOR MULTIPLE-MYELOMA INCREASES SEROLOGICAL RESPONSES BUT NOT OVERALL SURVIVAL OR THE NUMBER OF STABLE CLINICAL-RESPONSES, British Journal of Haematology, 93, 1996, pp. 296-296
INTERFERON-ALPHA-2B TREATMENT USED IN PLATEAU-PHASE OF MULTIPLE-MYELOMA INCREASES RELAPSE-FREE INTERVAL BUT NOT OVERALL SURVIVAL
Authors: DRAYSON MT DUNN JA OLUJOHUNGBE AB MACLENNAN ICM
Citation: Mt. Drayson et al., INTERFERON-ALPHA-2B TREATMENT USED IN PLATEAU-PHASE OF MULTIPLE-MYELOMA INCREASES RELAPSE-FREE INTERVAL BUT NOT OVERALL SURVIVAL, Blood, 88(10), 1996, pp. 2332-2332
MAB CLUSTERS REACTING WITH B-CELLS AND FOLLICULAR DENDRITIC CELLS
Authors: HARDIE DL HILL D CASAMAYOR M JOHNSON GD KHAN M MACLENNAN ICM
Citation: Dl. Hardie et al., MAB CLUSTERS REACTING WITH B-CELLS AND FOLLICULAR DENDRITIC CELLS, Tissue antigens, 48(4-II), 1996, pp. 201-201
SELECTIVE REACTIVITY OF THE B-CELL PANEL MABS WITH GERMINAL CENTER B-CELLS
Authors: HARDIE DL HILL D CASAMAYOR M JOHNSON GD KHAN M MACLENNAN ICM
Citation: Dl. Hardie et al., SELECTIVE REACTIVITY OF THE B-CELL PANEL MABS WITH GERMINAL CENTER B-CELLS, Tissue antigens, 48(4-II), 1996, pp. 206-206
REACTIVITY OF THE B-PANEL MABS WITH NONLYMPHOID CONSTITUENTS OF NORMAL-TISSUES
Authors: JOHNSON GD HARDIE DL KHAN M NEWTON JP SIMMONS D MACLENNAN ICM
Citation: Gd. Johnson et al., REACTIVITY OF THE B-PANEL MABS WITH NONLYMPHOID CONSTITUENTS OF NORMAL-TISSUES, Tissue antigens, 48(4-II), 1996, pp. 208-208
AUTOIMMUNITY - DELETION OF AUTOREACTIVE B-CELLS
Authors: MACLENNAN ICM
Citation: Icm. Maclennan, AUTOIMMUNITY - DELETION OF AUTOREACTIVE B-CELLS, Current biology, 5(2), 1995, pp. 103-106
EFFECT OF CLODRONATE ON PROGRESSION OF SKELETAL DISEASE IN MULTIPLE MYELOMATOSIS
Authors: MCCLOSKEY EV MACLENNAN ICM DRAYSON M CHAPMAN C DUNN J KANIS JA
Citation: Ev. Mccloskey et al., EFFECT OF CLODRONATE ON PROGRESSION OF SKELETAL DISEASE IN MULTIPLE MYELOMATOSIS, European journal of cancer, 31A, 1995, pp. 775-775
ISOLATION AND CHARACTERISTICS OF TONSIL CENTROBLASTS WITH REFERENCE TO IG CLASS SWITCHING
Authors: FEUILLARD J TAYLOR D CASAMAYORPALLEJA M JOHNSON GD MACLENNAN ICM
Citation: J. Feuillard et al., ISOLATION AND CHARACTERISTICS OF TONSIL CENTROBLASTS WITH REFERENCE TO IG CLASS SWITCHING, International immunology, 7(1), 1995, pp. 121-130
PERSISTENT GROWTH OF BALB C MOUSE PLASMACYTOMA AND HUMAN MYELOMA CELL-LINES IN THE PRESENCE OF PHORBOL-MYRISTATE ACETATE IS ASSOCIATED WITHCONTINUED EXPRESSION OF LAP18 (STATHMIN)/
Authors: JONES NA ROWLANDS DC JOHNSON WEB MACLENNAN ICM BROWN G
Citation: Na. Jones et al., PERSISTENT GROWTH OF BALB C MOUSE PLASMACYTOMA AND HUMAN MYELOMA CELL-LINES IN THE PRESENCE OF PHORBOL-MYRISTATE ACETATE IS ASSOCIATED WITHCONTINUED EXPRESSION OF LAP18 (STATHMIN)/, Hematological oncology, 13(1), 1995, pp. 29-43
Risultati: 1-25 | 26-37